Aripiprazole Open-Label, Safety and Tolerability Study
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the long-term safety and tolerability of aripiprazole in
adolescent patients with schizophrenia, and child and adolescent patients with bipolar I
disorder, manic or mixed episode.
Phase:
Phase 3
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.